Clin Endosc.  2015 Jul;48(4):336-339. 10.5946/ce.2015.48.4.336.

A Patient with Duodenal Mucinous Adenocarcinoma Presenting as a Laterally Spreading Tumor

Affiliations
  • 1Department of Gastroenterology, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul, Korea. topcolon@nate.com

Abstract

Primary duodenal carcinoma is rare. Duodenal mucinous adenocarcinoma (DMA) is even rarer, and its associated manifestations and typical endoscopic or imaging findings are not well characterized. Herein, we report a case of primary DMA in an asymptomatic 58-year-old man who visited our hospital for a regular health screening. Upper endoscopy revealed an approximately 4-cm lesion in the second portion of the duodenum, but the mass was not visualized on computed tomography. Biopsies revealed a tubular adenoma that was subsequently resected. Frozen biopsies demonstrated DMA with a background of low-grade tubular adenoma for which we performed Roux-en-Y duodenojejunostomy and jejunojejunostomy. To our knowledge, this is the first report of a patient with DMA in Korea.

Keyword

Adenocarcinoma; Mucinous; Duodenal neoplasms; Adenoma

MeSH Terms

Adenocarcinoma
Adenocarcinoma, Mucinous*
Adenoma
Biopsy
Duodenal Neoplasms
Duodenum
Endoscopy
Humans
Korea
Mass Screening
Middle Aged

Figure

  • Fig. 1 Esophagogastroduodenoscopy. (A) A laterally spreading polyp with an irregular surface is visible in the second portion of the duodenum. (B) Follow-up endoscopy after 3 months, showing no evidence of recurrence or abnormal findings at the anastomosis within the duodenum.

  • Fig. 2 Duodenal biopsy histology. These show malignant cells floating in large pools of mucin (A, H&E stain, ×40; B, H&E stain, ×100).


Reference

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014; 64:9–29. PMID: 24399786.
Article
2. Bilimoria KY, Bentrem DJ, Wayne JD, Ko CY, Bennett CL, Talamonti MS. Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg. 2009; 249:63–71. PMID: 19106677.
3. Yagyu T, Aihara T, Murayama M, et al. Mucinous carcinoma of the duodenum associated with hereditary nonpolyposis colorectal cancer: report of a case. Surg Today. 2006; 36:1129–1132. PMID: 17123147.
Article
4. Inagaki M, Obara M, Suzuki S, et al. Mucinous carcinoma of Vater's ampulla with a unique extension along the main pancreatic duct. J Hepatobiliary Pancreat Surg. 2007; 14:518–521. PMID: 17909724.
Article
5. Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer. 2004; 101:518–526. PMID: 15274064.
6. Aparicio T, Zaanan A, Svrcek M, et al. Small bowel adenocarcinoma: epidemiology, risk factors, diagnosis and treatment. Dig Liver Dis. 2014; 46:97–104. PMID: 23796552.
Article
7. Kummar S, Ciesielski TE, Fogarasi MC. Management of small bowel adenocarcinoma. Oncology (Williston Park). 2002; 16:1364–1369. PMID: 12435206.
8. Faivre J, Trama A, De Angelis R, et al. Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995-2002. Eur J Cancer. 2012; 48:1417–1424. PMID: 22169462.
Article
9. Chow JS, Chen CC, Ahsan H, Neugut AI. A population-based study of the incidence of malignant small bowel tumours: SEER, 1973-1990. Int J Epidemiol. 1996; 25:722–728. PMID: 8921448.
Article
10. Michelassi F, Testa G, Pomidor WJ, Lashner BA, Block GE. Adenocarcinoma complicating Crohn's disease. Dis Colon Rectum. 1993; 36:654–661. PMID: 8348849.
Article
11. Halfdanarson TR, McWilliams RR, Donohue JH, Quevedo JF. A single-institution experience with 491 cases of small bowel adenocarcinoma. Am J Surg. 2010; 199:797–803. PMID: 20609724.
Article
12. Abrahams NA, Halverson A, Fazio VW, Rybicki LA, Goldblum JR. Adenocarcinoma of the small bowel: a study of 37 cases with emphasis on histologic prognostic factors. Dis Colon Rectum. 2002; 45:1496–1502. PMID: 12432298.
13. Jass JR, Sobin LH. Histologic Typing of Intestinal Tumours. 2nd ed. Berlin: Springer Verlag;1989.
14. Yasuda K, Adachi Y, Shiraishi N, Yamaguchi K, Shiromizu A, Kitano S. Pathology and prognosis of mucinous gastric carcinoma. J Surg Oncol. 2001; 76:272–277. PMID: 11320519.
Article
15. Verhulst J, Ferdinande L, Demetter P, Ceelen W. Mucinous subtype as prognostic factor in colorectal cancer: a systematic review and meta-analysis. J Clin Pathol. 2012; 65:381–388. PMID: 22259177.
Article
16. Hirota E, Ochiai A, Oda Y, et al. Significance of histological type of gastric carcinoma as a prognostic factor. Stomach Intest. 1991; 26:1149–1158.
17. Adachi Y, Mori M, Kido A, Shimono R, Maehara Y, Sugimachi K. A clinicopathologic study of mucinous gastric carcinoma. Cancer. 1992; 69:866–871. PMID: 1310432.
Article
18. Yasuda K, Shiraishi N, Inomata M, Shiroshita H, Ishikawa K, Kitano S. Clinicopathologic characteristics of early-stage mucinous gastric carcinoma. J Clin Gastroenterol. 2004; 38:507–511. PMID: 15220686.
Article
19. Standards of Practice Committee. Adler DG, Qureshi W, et al. The role of endoscopy in ampullary and duodenal adenomas. Gastrointest Endosc. 2006; 64:849–854. PMID: 17140885.
Article
Full Text Links
  • CE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr